Skip to main content
Top
Published in: Journal of Inflammation 1/2015

Open Access 01-12-2015 | Short Report

Serum biomarkers VEGF-C and IL-6 are associated with severe human Peripheral Artery Stenosis

Authors: Jiexia Chen, Lei Han, Xiaoyan Xu, Haiqin Tang, Hongyan Wang, Bin Wei

Published in: Journal of Inflammation | Issue 1/2015

Login to get access

Abstract

Background

Emerging reports propose possible biomarkers that are related to inflammation, nutrition and lipid parameters for detection of the progression of atherosclerotic plaques, peripheral artery disease (PAD) and particularly peripheral artery stenosis (PAS). However, it remains unclear which biomarkers in serum are associated with the severity of PAS.

Findings

In this study, we measured serum levels of inflammatory biomarkers along with lipid and nutritional parameters in 53 patients who suffered different degrees of PAS. Serum concentrations of vascular endothelial growth factor-c (VEGF-C) and IL-6 (Interleukin 6) were significantly increased in patients showing moderate or severe PAS. Furthermore, the number of blood monocytes from PAS patients was significantly increased, which showed elevated adhesion to plate-coated fibrinogen. Compared to healthy subjects, freshly isolated or LPS (lipopolysaccharide)-stimulated blood monocytes from PAS patients could produce VEGF-C and IL-6 at higher levels.

Conclusions

Our study suggests that the increased number of blood monocytes might play key roles during the development of severe PAS, which enhance adhesion at the local narrowed peripheral artery and secret high levels of VEGF-C and IL-6. We suggest that serum concentrations of VEGF-C and IL-6 might be used as biomarkers for diagnosis severe PAS in combination with clinical imaging examination.
Appendix
Available only for authorised users
Literature
1.
go back to reference Chakfe N, Ohana M. Commentary on "MRI-derived Arterial Peak Flow in Peripheral Arterial Disease: Towards a Standardized Measurement". Eur J Vasc Endovasc. 2014;48(2):193–3.CrossRef Chakfe N, Ohana M. Commentary on "MRI-derived Arterial Peak Flow in Peripheral Arterial Disease: Towards a Standardized Measurement". Eur J Vasc Endovasc. 2014;48(2):193–3.CrossRef
2.
go back to reference Signorelli SS, Fiore V, Malaponte G. Inflammation and peripheral arterial disease: the value of circulating biomarkers (Review). Int J Mol Med. 2014;33(4):777–83.PubMed Signorelli SS, Fiore V, Malaponte G. Inflammation and peripheral arterial disease: the value of circulating biomarkers (Review). Int J Mol Med. 2014;33(4):777–83.PubMed
3.
go back to reference Signorelli SS, Anzaldi M, Fiore V. Inflammation in Peripheral Arterial Disease (PAD). Curr Pharm Design. 2012;18(28):4350–7.CrossRef Signorelli SS, Anzaldi M, Fiore V. Inflammation in Peripheral Arterial Disease (PAD). Curr Pharm Design. 2012;18(28):4350–7.CrossRef
4.
go back to reference Angelidis C, Deftereos S, Giannopoulos G, Anatoliotakis N, Bouras G, Hatzis G, et al. Cystatin C: an emerging biomarker in cardiovascular disease. Curr Top Med Chem. 2013;13(2):164–79.CrossRefPubMed Angelidis C, Deftereos S, Giannopoulos G, Anatoliotakis N, Bouras G, Hatzis G, et al. Cystatin C: an emerging biomarker in cardiovascular disease. Curr Top Med Chem. 2013;13(2):164–79.CrossRefPubMed
5.
go back to reference Tousoulis D, Kampoli AM, Papageorgiou N, Androulakis E, Antoniades C, Toutouzas K, et al. Pathophysiology of atherosclerosis: the role of inflammation. Curr Pharm Design. 2011;17(37):4089–110.CrossRef Tousoulis D, Kampoli AM, Papageorgiou N, Androulakis E, Antoniades C, Toutouzas K, et al. Pathophysiology of atherosclerosis: the role of inflammation. Curr Pharm Design. 2011;17(37):4089–110.CrossRef
6.
go back to reference Lee PP. Early detection of moderate glaucoma: redefining clinical care in 2001. Arch Ophthalmol-Chic. 2001;119(7):1069–70.CrossRef Lee PP. Early detection of moderate glaucoma: redefining clinical care in 2001. Arch Ophthalmol-Chic. 2001;119(7):1069–70.CrossRef
7.
go back to reference Zhang Y, Lu Y, Ma L, Cao X, Xiao J, Chen J, et al. Activation of vascular endothelial growth factor receptor-3 in macrophages restrains TLR4-NF-kappaB signaling and protects against endotoxin shock. Immunity. 2014;40(4):501–14.CrossRefPubMed Zhang Y, Lu Y, Ma L, Cao X, Xiao J, Chen J, et al. Activation of vascular endothelial growth factor receptor-3 in macrophages restrains TLR4-NF-kappaB signaling and protects against endotoxin shock. Immunity. 2014;40(4):501–14.CrossRefPubMed
8.
go back to reference Olsson AK, Dimberg A, Kreuger J, Claesson-Welsh L. VEGF receptor signalling - in control of vascular function. Nat Rev Mol Cell Biol. 2006;7(5):359–71.CrossRefPubMed Olsson AK, Dimberg A, Kreuger J, Claesson-Welsh L. VEGF receptor signalling - in control of vascular function. Nat Rev Mol Cell Biol. 2006;7(5):359–71.CrossRefPubMed
9.
go back to reference Fitz LJ, Morris JC, Towler P, Long A, Burgess P, Greco R, et al. Characterization of murine Flt4 ligand/VEGF-C. Oncogene. 1997;15(5):613–8.CrossRefPubMed Fitz LJ, Morris JC, Towler P, Long A, Burgess P, Greco R, et al. Characterization of murine Flt4 ligand/VEGF-C. Oncogene. 1997;15(5):613–8.CrossRefPubMed
10.
go back to reference Iwami D, Brinkman CC, Bromberg JS. Vascular endothelial growth factor c/vascular endothelial growth factor receptor 3 signaling regulates chemokine gradients and lymphocyte migration from tissues to lymphatics. Transplantation. 2015;99(4):668–77.CrossRefPubMed Iwami D, Brinkman CC, Bromberg JS. Vascular endothelial growth factor c/vascular endothelial growth factor receptor 3 signaling regulates chemokine gradients and lymphocyte migration from tissues to lymphatics. Transplantation. 2015;99(4):668–77.CrossRefPubMed
11.
go back to reference Skobe M, Hamberg LM, Hawighorst T, Schirner M, Wolf GL, Alitalo K, et al. Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma. Am J Pathol. 2001;159(3):893–903.PubMedCentralCrossRefPubMed Skobe M, Hamberg LM, Hawighorst T, Schirner M, Wolf GL, Alitalo K, et al. Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma. Am J Pathol. 2001;159(3):893–903.PubMedCentralCrossRefPubMed
12.
go back to reference Kimura K, Hashiguchi T, Deguchi T, Horinouchi SI, Uto T, Oku H, et al. Serum VEGF - As a prognostic factor of atherosclerosis. Atherosclerosis. 2007;194(1):182–8.CrossRefPubMed Kimura K, Hashiguchi T, Deguchi T, Horinouchi SI, Uto T, Oku H, et al. Serum VEGF - As a prognostic factor of atherosclerosis. Atherosclerosis. 2007;194(1):182–8.CrossRefPubMed
13.
go back to reference van der Flier M, van Leeuwen HJ, van Kessel KP, Kimpen JL, Hoepelman AI, Geelen SP. Plasma vascular endothelial growth factor in severe sepsis. Shock. 2005;23(1):35–8.CrossRefPubMed van der Flier M, van Leeuwen HJ, van Kessel KP, Kimpen JL, Hoepelman AI, Geelen SP. Plasma vascular endothelial growth factor in severe sepsis. Shock. 2005;23(1):35–8.CrossRefPubMed
14.
go back to reference Yano K, Liaw PC, Mullington JM, Shih SC, Okada H, Bodyak N, et al. Vascular endothelial growth factor is an important determinant of sepsis morbidity and mortality. J Exp Med. 2006;203(6):1447–58.PubMedCentralCrossRefPubMed Yano K, Liaw PC, Mullington JM, Shih SC, Okada H, Bodyak N, et al. Vascular endothelial growth factor is an important determinant of sepsis morbidity and mortality. J Exp Med. 2006;203(6):1447–58.PubMedCentralCrossRefPubMed
15.
go back to reference Fogelman AM, Elahi F, Sykes K, Van Lenten BJ, Territo MC, Berliner JA. Modification of the Recalde method for the isolation of human monocytes. J Lipid Res. 1988;29(9):1243–7.PubMed Fogelman AM, Elahi F, Sykes K, Van Lenten BJ, Territo MC, Berliner JA. Modification of the Recalde method for the isolation of human monocytes. J Lipid Res. 1988;29(9):1243–7.PubMed
16.
go back to reference Plenz G, Robenek H. Monocytes/macrophages in atherosclerosis. Eur Cytokine Netw. 1998;9(4):701–3.PubMed Plenz G, Robenek H. Monocytes/macrophages in atherosclerosis. Eur Cytokine Netw. 1998;9(4):701–3.PubMed
17.
go back to reference White NJ, Newton JC, Martin EJ, Mohammed BM, Contaifer Jr D, Bostic JL, et al. Clot Formation is Associated With Fibrinogen and Platelet Forces in a Cohort of Severely-Injured Emergency Department Trauma Patients. Shock. 2015. White NJ, Newton JC, Martin EJ, Mohammed BM, Contaifer Jr D, Bostic JL, et al. Clot Formation is Associated With Fibrinogen and Platelet Forces in a Cohort of Severely-Injured Emergency Department Trauma Patients. Shock. 2015.
18.
go back to reference Jae SY, Kurl S, Laukkanen JA, Lee CD, Choi YH, Fernhall B, et al. Relation of C-reactive protein, fibrinogen, and cardiorespiratory fitness to risk of systemic hypertension in men. Am J Cardiol. 2015;115(12):1714–9.CrossRefPubMed Jae SY, Kurl S, Laukkanen JA, Lee CD, Choi YH, Fernhall B, et al. Relation of C-reactive protein, fibrinogen, and cardiorespiratory fitness to risk of systemic hypertension in men. Am J Cardiol. 2015;115(12):1714–9.CrossRefPubMed
19.
go back to reference Frostegard J, Ulfgren AK, Nyberg P, Hedin U, Swedenborg J, Andersson U, et al. Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines. Atherosclerosis. 1999;145(1):33–43.CrossRefPubMed Frostegard J, Ulfgren AK, Nyberg P, Hedin U, Swedenborg J, Andersson U, et al. Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines. Atherosclerosis. 1999;145(1):33–43.CrossRefPubMed
20.
go back to reference Kakafika AI, Liberopoulos EN, Mikhailidis DP. Fibrinogen: a predictor of vascular disease. Curr Pharm Des. 2007;13(16):1647–59.CrossRefPubMed Kakafika AI, Liberopoulos EN, Mikhailidis DP. Fibrinogen: a predictor of vascular disease. Curr Pharm Des. 2007;13(16):1647–59.CrossRefPubMed
21.
go back to reference Smith EB. Fibrinogen, fibrin and fibrin degradation products in relation to atherosclerosis. Clin Haematol. 1986;15(2):355–70.PubMed Smith EB. Fibrinogen, fibrin and fibrin degradation products in relation to atherosclerosis. Clin Haematol. 1986;15(2):355–70.PubMed
22.
go back to reference Adams RH, Alitalo K. Molecular regulation of angiogenesis and lymphangiogenesis. Nat Rev Mol Cell Biol. 2007;8(6):464–78.CrossRefPubMed Adams RH, Alitalo K. Molecular regulation of angiogenesis and lymphangiogenesis. Nat Rev Mol Cell Biol. 2007;8(6):464–78.CrossRefPubMed
23.
go back to reference Lohela M, Bry M, Tammela T, Alitalo K. VEGFs and receptors involved in angiogenesis versus lymphangiogenesis. Curr Opin Cell Biol. 2009;21(2):154–65.CrossRefPubMed Lohela M, Bry M, Tammela T, Alitalo K. VEGFs and receptors involved in angiogenesis versus lymphangiogenesis. Curr Opin Cell Biol. 2009;21(2):154–65.CrossRefPubMed
25.
go back to reference Griffiths EK, Krawczyk C, Kong YY, Raab M, Hyduk SJ, Bouchard D, et al. Positive regulation of T cell activation and integrin adhesion by the adapter Fyb/Slap. Science. 2001;293(5538):2260–3.CrossRefPubMed Griffiths EK, Krawczyk C, Kong YY, Raab M, Hyduk SJ, Bouchard D, et al. Positive regulation of T cell activation and integrin adhesion by the adapter Fyb/Slap. Science. 2001;293(5538):2260–3.CrossRefPubMed
26.
go back to reference Peterson EJ, Woods ML, Dmowski SA, Derimanov G, Jordan MS, Wu JN, et al. Coupling of the TCR to integrin activation by Slap-130/Fyb. Science. 2001;293(5538):2263–5.CrossRefPubMed Peterson EJ, Woods ML, Dmowski SA, Derimanov G, Jordan MS, Wu JN, et al. Coupling of the TCR to integrin activation by Slap-130/Fyb. Science. 2001;293(5538):2263–5.CrossRefPubMed
27.
go back to reference Wang H, McCann FE, Gordan JD, Wu X, Raab M, Malik TH, et al. ADAP-SLP-76 binding differentially regulates supramolecular activation cluster (SMAC) formation relative to T cell-APC conjugation. J Exp Med. 2004;200(8):1063–74.PubMedCentralCrossRefPubMed Wang H, McCann FE, Gordan JD, Wu X, Raab M, Malik TH, et al. ADAP-SLP-76 binding differentially regulates supramolecular activation cluster (SMAC) formation relative to T cell-APC conjugation. J Exp Med. 2004;200(8):1063–74.PubMedCentralCrossRefPubMed
28.
go back to reference Wang H, Wei B, Bismuth G, Rudd CE. SLP-76-ADAP adaptor module regulates LFA-1 mediated costimulation and T cell motility. Proc Natl Acad Sci USA. 2009;106(30):12436–41.PubMedCentralCrossRefPubMed Wang H, Wei B, Bismuth G, Rudd CE. SLP-76-ADAP adaptor module regulates LFA-1 mediated costimulation and T cell motility. Proc Natl Acad Sci USA. 2009;106(30):12436–41.PubMedCentralCrossRefPubMed
29.
go back to reference Li C, Jiao S, Wang G, Gao Y, Liu C, He X, et al. The Immune Adaptor ADAP Regulates Reciprocal TGF-beta1-Integrin Crosstalk to Protect from Influenza Virus Infection. PLoS Pathog. 2015;11(4), e1004824.PubMedCentralCrossRefPubMed Li C, Jiao S, Wang G, Gao Y, Liu C, He X, et al. The Immune Adaptor ADAP Regulates Reciprocal TGF-beta1-Integrin Crosstalk to Protect from Influenza Virus Infection. PLoS Pathog. 2015;11(4), e1004824.PubMedCentralCrossRefPubMed
30.
go back to reference Li C, Li W, Xiao J, Jiao S, Teng F, Xue S, et al. ADAP and SKAP55 deficiency suppresses PD-1 expression in CD8+ cytotoxic T lymphocytes for enhanced anti-tumor immunotherapy. EMBO Mol Med. 2015;7(6):754-769. Li C, Li W, Xiao J, Jiao S, Teng F, Xue S, et al. ADAP and SKAP55 deficiency suppresses PD-1 expression in CD8+ cytotoxic T lymphocytes for enhanced anti-tumor immunotherapy. EMBO Mol Med. 2015;7(6):754-769.
31.
go back to reference Wang H, Lim D, Rudd CE. Immunopathologies linked to integrin signalling. Semin Immunopathol. 2010;32(2):173–82. Wang H, Lim D, Rudd CE. Immunopathologies linked to integrin signalling. Semin Immunopathol. 2010;32(2):173–82.
32.
go back to reference Alenghat FJ, Baca QJ, Rubin NT, Pao LI, Matozaki T, Lowell CA, et al. Macrophages require Skap2 and Sirpalpha for integrin-stimulated cytoskeletal rearrangement. J Cell Sci. 2012;125(Pt 22):5535–45. Alenghat FJ, Baca QJ, Rubin NT, Pao LI, Matozaki T, Lowell CA, et al. Macrophages require Skap2 and Sirpalpha for integrin-stimulated cytoskeletal rearrangement. J Cell Sci. 2012;125(Pt 22):5535–45.
33.
go back to reference Swanson KD, Tang Y, Ceccarelli DF, Poy F, Sliwa JP, Neel BG, et al. The Skap-hom dimerization and PH domains comprise a 3'-phosphoinositide-gated molecular switch. Mol Cell. 2008;32(4):564–75. Swanson KD, Tang Y, Ceccarelli DF, Poy F, Sliwa JP, Neel BG, et al. The Skap-hom dimerization and PH domains comprise a 3'-phosphoinositide-gated molecular switch. Mol Cell. 2008;32(4):564–75.
Metadata
Title
Serum biomarkers VEGF-C and IL-6 are associated with severe human Peripheral Artery Stenosis
Authors
Jiexia Chen
Lei Han
Xiaoyan Xu
Haiqin Tang
Hongyan Wang
Bin Wei
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Journal of Inflammation / Issue 1/2015
Electronic ISSN: 1476-9255
DOI
https://doi.org/10.1186/s12950-015-0095-y

Other articles of this Issue 1/2015

Journal of Inflammation 1/2015 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.